ID   TB1A2
AC   CVCL_1D84
DR   Wikidata; Q54971747
RX   PubMed=8691151;
WW   Provider; NIH OTT; E-342-2008/0-49; https://web.archive.org/web/20150922074851/http://www.ott.nih.gov/erma/tb1a2-cells-are-defective-protein-tyrosine-kinase-syk-immunoglobulin-ige-receptor-induced
CC   Characteristics: Deficient in the expression of SYK (PubMed=8691151).
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
RX   PubMed=8691151; DOI=10.1084/jem.184.1.71; PMCID=PMC2192664;
RA   Zhang J., Berenstein E.H., Evans R.L., Siraganian R.P.;
RT   "Transfection of Syk protein tyrosine kinase reconstitutes high
RT   affinity IgE receptor-mediated degranulation in a Syk-negative variant
RT   of rat basophilic leukemia RBL-2H3 cells.";
RL   J. Exp. Med. 184:71-79(1996).
//